Premier Asset Management LLC Amgen Inc Transaction History

Premier Asset Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 10, 2022	SELL	$198.88 - $227.6 $1.64 Million - $1.88 Million	-8,264 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$212.27 - $248.7 $471,239 - $552,114	2,220 Added 36.73%	8,264 $1.76 Million
Q2 2021 Aug 16, 2021	BUY	$233.58 - $259.14 $40,642 - $45,090	174 Added 2.96%	6,044 $1.47 Million
Q1 2021 May 12, 2021	BUY	$221.91 - $258.6 $219,247 - $255,496	988 Added 20.24%	5,870 $1.46 Million
Q4 2020 Feb 16, 2021	BUY	$216.38 - $257.67 $435,356 - $518,432	2,012 Added 70.1%	4,882 $1.12 Million
Q3 2020 Nov 16, 2020	BUY	$234.65 - $260.95 $673,445 - $748,926	2,870 New	2,870 $729,000

3,123

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $150B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Premier Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Premier Asset Management LLC with notifications on news.